Cargando…

Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers

INTRODUCTION: Treatment of oesophageal (OC), gastro-oesophageal junction (GOJ), and gastric cancer (GC) includes either neoadjuvant Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) for OC or GOJ or perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahnam, Adel, Nindra, Udit, McNamee, Nicholas, Yoon, Robert, Asghari, Ray, Ng, Weng, Karikios, Deme, Wong, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601866/ https://www.ncbi.nlm.nih.gov/pubmed/37901653 http://dx.doi.org/10.1159/000531536

Ejemplares similares

Haematological and nutritional prognostic biomarkers for patients receiving CROSS or FLOT
por: McNamee, Nicholas, et al.
Publicado: (2023)

FLOT and CROSS chemotherapy regimens alter the frequency of CD27(+) and CD69(+) T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy
por: Davern, Maria, et al.
Publicado: (2022)

Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study
por: Moussa, Osama, et al.
Publicado: (2022)

Results of the observational prospective RealFLOT study
por: Giommoni, Elisa, et al.
Publicado: (2021)

Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)
por: EROL, Cihan, et al.
Publicado: (2022)

Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study
por: Du, Rongxu, et al.
Publicado: (2022)

Se maintenir à flot
por: Auer, Rebecca Ann C.
Publicado: (2021)

Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab
por: Nindra, Udit, et al.
Publicado: (2022)

Un flot ininterrompu de données
por: Ourghanlian, Bernard
Publicado: (2006)

Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study
por: Tong, Gangling, et al.
Publicado: (2020)

The roles of FLOT1 in human diseases (Review)
por: Zhan, Ziqing, et al.
Publicado: (2023)

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
por: Götze, Thorsten O., et al.
Publicado: (2021)

1389P Real world outcomes of locally advanced gastric/GOJ cancers receiving perioperative chemotherapy with FLOT regimen during the COVID-19 pandemic: Results from a regional cancer care centre in the UK
por: Bose, S., et al.
Publicado: (2021)

Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis
por: ter Veer, Emil, et al.
Publicado: (2017)

Efficacy and safety of FLOT regimen vs DCF, FOLFOX, and ECF regimens as perioperative chemotherapy treatments for resectable gastric cancer patients; a report from the middle east
por: Farrokhi, Pegah, et al.
Publicado: (2022)

The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
por: Flynn, Michael, et al.
Publicado: (2018)

Laparoscopic vs. open feeding jejunostomy insertion in oesophagogastric cancer
por: Mastoridis, Sotiris, et al.
Publicado: (2021)

Evaluation of Pathological Response Rate and Complications of FOLFOX versus FLOT Regimen in Perioperative Chemotherapy for Resectable Gastric Cancer: A Prospective Study
por: Arefpour, Amir Mohammad, et al.
Publicado: (2023)

Delayed Posterior Reversible Leukoencephalopathy Syndrome Triggered by FLOT Chemotherapy
por: Gandini, Jordi, et al.
Publicado: (2020)

Similar pharmacokinetics of three dosing regimens comprising two oral delayed‐release mesalamine formulations in healthy adult volunteers: Randomised, open‐label, parallel‐group study
por: Vande Casteele, Niels, et al.
Publicado: (2020)

Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab
por: Schade, Sebastian, et al.
Publicado: (2022)

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions
por: Bose, Katrin, et al.
Publicado: (2017)

Concurrent Paraneoplastic Dermatomyositis and Acquired C1 Esterase Inhibitor Deficiency in Primary Laryngeal Small Cell Carcinoma
por: Nindra, Udit, et al.
Publicado: (2021)

Exploring the impact and experience of fractional work in medicine: a qualitative study of medical oncologists in Australia
por: Kirby, Emma, et al.
Publicado: (2019)

Identification of Novel Raft Marker Protein, FlotP in Bacillus anthracis
por: Somani, Vikas K., et al.
Publicado: (2016)

FLOT2 overexpression is associated with the progression and prognosis of human colorectal cancer
por: Li, Taiyuan, et al.
Publicado: (2019)

Dynamics and Endocytosis of Flot1 in Arabidopsis Require CPI1 Function
por: Cao, Yangyang, et al.
Publicado: (2020)

Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population
por: Nindra, Udit, et al.
Publicado: (2023)

Laparoscopic fundoplication and new aspects of neural anatomy at the oesophagogastric junction
por: Gehwolf, P., et al.
Publicado: (2020)

A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma
por: Nindra, Udit, et al.
Publicado: (2023)

Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia
por: Agarwal, Anupriya, et al.
Publicado: (2022)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Shi-Hong, et al.
Publicado: (2013)

An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric Cancers
por: Bhargava, Prabhat, et al.
Publicado: (2022)

General practitioner knowledge, skills and attitudes to eating disorders
por: Doherty, S, et al.
Publicado: (2015)

Gene Transfer for Pain: A tool to cope with the intractable, or an unethical enduranceenhancing technology?
por: Camporesi, S, et al.
Publicado: (2012)

A Qualitative Study of Medical Oncologists’ Experiences of Their Profession and Workforce Sustainability
por: Broom, Alex, et al.
Publicado: (2016)

A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular Tumour
por: Hong, Jun Hee, et al.
Publicado: (2022)

Discussing and prescribing expensive unfunded anticancer drugs in Australia
por: Karikios, Deme John, et al.
Publicado: (2017)

Cardiopulmonary exercise testing as a predictor of complications in oesophagogastric cancer surgery
por: Moyes, LH, et al.
Publicado: (2013)

Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
por: Schmidt, T, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6cchfomes0cq5jp4hh9p58a97p